東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The transcription factor nuclear fac...

Tsai, Jennifer Jia-ying.

FindBook

Google Book

Amazon

博客來

The transcription factor nuclear factor erythroid-2 related 2 regulates hematopoietic stem cell function and T-cell alloreactivity.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The transcription factor nuclear factor erythroid-2 related 2 regulates hematopoietic stem cell function and T-cell alloreactivity./
作者:	Tsai, Jennifer Jia-ying.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2016,
面頁冊數:	83 p.
附註:	Source: Dissertation Abstracts International, Volume: 78-03(E), Section: B.
Contained By:	Dissertation Abstracts International78-03B(E).
標題:	Biology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10154170
ISBN:	9781369092905

The transcription factor nuclear factor erythroid-2 related 2 regulates hematopoietic stem cell function and T-cell alloreactivity.
Tsai, Jennifer Jia-ying.

The transcription factor nuclear factor erythroid-2 related 2 regulates hematopoietic stem cell function and T-cell alloreactivity. - Ann Arbor : ProQuest Dissertations & Theses, 2016 - 83 p.

Source: Dissertation Abstracts International, Volume: 78-03(E), Section: B.

Thesis (Ph.D.)--Weill Medical College of Cornell University, 2016.

Coordinating the balance between haematopoietic stem cell (HSC) quiescence and self-renewal is crucial for maintaining haematopoiesis lifelong. Equally important for haematopoietic function is modulating their localisation within their bone marrow niches, as maintenance of HSC function is tightly controlled by a complex network of intrinsic molecular mechanisms and extrinsic signalling interactions with their surrounding microenvironment. Recent findings have suggested that a common mediator of these functions is the CXCR4-CXCL12 axis. In the first part of the dissertation, we demonstrate that nuclear factor erythroid 2-related factor 2 (Nfe2l2, or Nrf2), well-established as a global regulator of oxidative stress response, plays a regulatory role in all these aspects of HSC homeostasis. Nrf2-deficiency results in an expansion of haematopoietic stem and progenitor cells (HSPCs) due to cell-intrinsic hyperproliferation, which was accomplished at the expense of HSC quiescence and self-renewal. We further show that Nrf2 mediates both migration and retention of HSCs in their niche. Moreover, we identify a previously unrecognized link between Nrf2 and CXCR4, contributing, at least partially, to the maintenance of the main modalities of HSC function.

ISBN: 9781369092905Subjects--Topical Terms:

522710
Biology.

The transcription factor nuclear factor erythroid-2 related 2 regulates hematopoietic stem cell function and T-cell alloreactivity.
LDR:04191nmm a2200313 4500 001 2120959
005 20170724102932.5
008 180830s2016 ||||||||||||||||| ||eng d
020 $a 9781369092905
035 $a (MiAaPQ)AAI10154170
035 $a AAI10154170
040 $a MiAaPQ $c MiAaPQ
100 1 $a Tsai, Jennifer Jia-ying. $3 3282936
245 1 4 $a The transcription factor nuclear factor erythroid-2 related 2 regulates hematopoietic stem cell function and T-cell alloreactivity.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2016
300 $a 83 p.
500 $a Source: Dissertation Abstracts International, Volume: 78-03(E), Section: B.
500 $a Adviser: Marcel R.M. van den Brink.
502 $a Thesis (Ph.D.)--Weill Medical College of Cornell University, 2016.
520 $a Coordinating the balance between haematopoietic stem cell (HSC) quiescence and self-renewal is crucial for maintaining haematopoiesis lifelong. Equally important for haematopoietic function is modulating their localisation within their bone marrow niches, as maintenance of HSC function is tightly controlled by a complex network of intrinsic molecular mechanisms and extrinsic signalling interactions with their surrounding microenvironment. Recent findings have suggested that a common mediator of these functions is the CXCR4-CXCL12 axis. In the first part of the dissertation, we demonstrate that nuclear factor erythroid 2-related factor 2 (Nfe2l2, or Nrf2), well-established as a global regulator of oxidative stress response, plays a regulatory role in all these aspects of HSC homeostasis. Nrf2-deficiency results in an expansion of haematopoietic stem and progenitor cells (HSPCs) due to cell-intrinsic hyperproliferation, which was accomplished at the expense of HSC quiescence and self-renewal. We further show that Nrf2 mediates both migration and retention of HSCs in their niche. Moreover, we identify a previously unrecognized link between Nrf2 and CXCR4, contributing, at least partially, to the maintenance of the main modalities of HSC function.
520 $a While there is mounting evidence including ours suggesting a critical role of Nrf2 in HSC homeostasis and lymphohematopoietic malignancies, little is known about its role in T-cell biology. In the second part of the dissertation, we evaluate the relative contribution of Nrf2 to alloreactive T cells in the context of allogeneic bone marrow transplant (allo-BMT). Allogeneic bone marrow transplant (allo-BMT) is the most potent modality of cellular immune therapy for lymphohematologic malignancies. The therapeutic benefits of allo-BMT are derived from the cytoreductive conditioning, as well as the immune-mediated graft-versus-tumor (GVT) effect. However, one of the main drawbacks to the widespread use of allo-BMT is graft-versus-host disease (GVHD). Allogeneic donor T (allo-T) lymphocytes are the primary mediators facilitating both GVT and GVHD responses. We validate the biological significance of Nrf2 in T lymphocytes by showing nuclear translocation of Nrf2 upon T cell activation in vitro, and an increased cellular Nrf2 level specifically within CD4+ donor T cells upon alloactivation in vivo. We demonstrate that Nrf2-deficiency in donor T cells leads to attenuated acute GVHD, which is associated with stabilization of Helios+ regulatory T cells, present in the graft at the time of transplant, as well as defective upregulation of the gut homing receptor LPAM-1 of CD8+ allo-T cells. However, Nrf2-/- donor CD8+ T cells possess intact killing ability against alloantigens and A20 lymphoma cells. With their preserved GVT activity and ameliorated GVHD severity, Nrf2-/- donor T cells conferred an overall improved survival in the tumor-bearing allo-BMT recipients. Our findings not only characterize a novel role of Nrf2 in T cell function, but also reveal an exciting target for therapeutic manipulation as a useful clinical strategy to improve the outcomes of allo-BMT.
590 $a School code: 0967.
650 4 $a Biology. $3 522710
650 4 $a Immunology. $3 611031
650 4 $a Medicine. $3 641104
690 $a 0306
690 $a 0982
690 $a 0564
710 2 $a Weill Medical College of Cornell University. $b Immunology and Microbial Pathogenesis. $3 3282937
773 0 $t Dissertation Abstracts International $g 78-03B(E).
790 $a 0967
791 $a Ph.D.
792 $a 2016
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10154170